{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:19:10Z","timestamp":1785417550231,"version":"3.56.0"},"posted":{"date-parts":[[2025,12,23]]},"group-title":"Neuroscience","reference-count":70,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["NIH, R01DK132088"],"award-info":[{"award-number":["NIH, R01DK132088"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["NIH, R01DK133326"],"award-info":[{"award-number":["NIH, R01DK133326"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["NIH, R01AG079257"],"award-info":[{"award-number":["NIH, R01AG079257"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["AHW, FP00028084"],"award-info":[{"award-number":["AHW, FP00028084"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by profound loss of dopaminergic (DA) neurons, yet the underlying mechanism remains incompletely defined. Mitochondrial toxins can induce acute degeneration of DA neurons and Parkinsonism-like phenotypes in animal models, and epidemiological studies have linked pesticide exposure to increased PD risk; however, the long-term effects of pesticide exposure remain elusive. Here, we examined both the acute and long-term effects of rotenone exposure in mice to understand PD onset, progression, and recovery. A 21-day regimen of rotenone intraperitoneal injections (2.5 mg\/kg\/day) induced robust Parkinsonism-like deficits by the 4\n                  <jats:sup>th<\/jats:sup>\n                  week, including impaired locomotion, increased anxiety-like behaviors, and deficits in motor balancing and coordination. These behavioral abnormalities were accompanied by pronounced reduction in tyrosine hydroxylase (TH) expression and selective loss of DA neurons in the substantia nigra pars compacta (SNc). Unexpectedly, these functional impairments fully resolved by 12 months, and rotenone-treated mice behaved equally well as age-matched controls. In parallel, the TH expression and DA neuron density in SNc were restored to control levels. Together, these longitudinal results demonstrate that chronic rotenone injection induces robust but reversible Parkinsonism in the acute phase, with limited long-term consequence on Parkinsonism upon toxin cessation. These findings contrast with the prevailing view that environmental pesticide exposure irreversibly drives PD and instead they reveal a substantial resilience and adaptive capacity of the nigrostriatal dopaminergic system in vivo.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Highlights<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Chronic rotenone exposure in mice induces robust Parkinsonism-like behaviors in both motor and non-motor domains.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>SNc dopaminergic neurons are reduced by \u223c40% at the acute phase within 4 weeks.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Both motor and non-motor deficits are fully recovered by 12 months.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>PD-like pathological changes in the SNc are resolved by 12 months.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Infographics<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"695709v1_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>","DOI":"10.64898\/2025.12.20.695709","type":"posted-content","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:55:14Z","timestamp":1766526914000},"source":"Crossref","is-referenced-by-count":1,"title":["Parkinsonism Reversal and Dopaminergic Resilience: Lessons from a Rotenone-induced Parkinson\u2019s Disease Model"],"prefix":"10.64898","author":[{"given":"Prince","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025122610051089000_2025.12.20.695709v1.1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","year":"2021","journal-title":"The Lancet"},{"key":"2025122610051089000_2025.12.20.695709v1.2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","year":"2023","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"2025122610051089000_2025.12.20.695709v1.3","doi-asserted-by":"crossref","unstructured":"H\u00f6llerhage, M . (2025). Pesticides and parkinson\u2019s disease: causal relationship at the population and individual level? Journal of Neural Transmission, 1\u201336.","DOI":"10.1007\/s00702-025-03054-3"},{"key":"2025122610051089000_2025.12.20.695709v1.4","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.114-a156"},{"key":"2025122610051089000_2025.12.20.695709v1.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318294b3c8"},{"key":"2025122610051089000_2025.12.20.695709v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/81834"},{"key":"2025122610051089000_2025.12.20.695709v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.12.006"},{"key":"2025122610051089000_2025.12.20.695709v1.8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson\u2019s disease","volume":"21","year":"2020","journal-title":"International journal of molecular sciences"},{"key":"2025122610051089000_2025.12.20.695709v1.9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.0c00522"},{"key":"2025122610051089000_2025.12.20.695709v1.10","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7"},{"key":"2025122610051089000_2025.12.20.695709v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/1055-8330(95)90015-2"},{"key":"2025122610051089000_2025.12.20.695709v1.12","doi-asserted-by":"publisher","DOI":"10.1006\/neur.1995.0016"},{"key":"2025122610051089000_2025.12.20.695709v1.13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508628200"},{"key":"2025122610051089000_2025.12.20.695709v1.14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","year":"2011","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"2025122610051089000_2025.12.20.695709v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.01.016"},{"key":"2025122610051089000_2025.12.20.695709v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00561-6"},{"key":"2025122610051089000_2025.12.20.695709v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(03)00172-1"},{"key":"2025122610051089000_2025.12.20.695709v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105685"},{"key":"2025122610051089000_2025.12.20.695709v1.19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s40478-025-02160-3","article-title":"Rotenone targets midbrain astrocytes to produce glial dysfunction-mediated dopaminergic neurodegeneration","volume":"13","year":"2025","journal-title":"Acta Neuropathologica Communications"},{"key":"2025122610051089000_2025.12.20.695709v1.20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","article-title":"Environment-contact administration of rotenone: A new rodent model of Parkinson\u2019s disease","volume":"294","year":"2015","journal-title":"Behavioural brain research"},{"key":"2025122610051089000_2025.12.20.695709v1.21","doi-asserted-by":"publisher","DOI":"10.1097\/Fbp.0000000000000389"},{"key":"2025122610051089000_2025.12.20.695709v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.12.052"},{"key":"2025122610051089000_2025.12.20.695709v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfz082"},{"key":"2025122610051089000_2025.12.20.695709v1.24","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.3390\/ijms232012658","article-title":"Non-reproducibility of oral rotenone as a model for Parkinson\u2019s disease in mice","volume":"23","year":"2022","journal-title":"International journal of molecular sciences"},{"key":"2025122610051089000_2025.12.20.695709v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2020.01.004"},{"key":"2025122610051089000_2025.12.20.695709v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.addicn.2024.100183"},{"key":"2025122610051089000_2025.12.20.695709v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0203-4"},{"key":"2025122610051089000_2025.12.20.695709v1.28","doi-asserted-by":"publisher","DOI":"10.20517\/and.2021.07"},{"key":"2025122610051089000_2025.12.20.695709v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109975"},{"key":"2025122610051089000_2025.12.20.695709v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/cne.20305"},{"key":"2025122610051089000_2025.12.20.695709v1.31","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15437"},{"key":"2025122610051089000_2025.12.20.695709v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(95)00571-4"},{"key":"2025122610051089000_2025.12.20.695709v1.33","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12459"},{"key":"2025122610051089000_2025.12.20.695709v1.34","first-page":"270","article-title":"Experimental modeling of functional deficiency of the nigrostriatal dopaminergic system in mice","volume":"96","year":"2010","journal-title":"Rossiiskii Fiziologicheskii Zhurnal Imeni IM Sechenova"},{"key":"2025122610051089000_2025.12.20.695709v1.35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","article-title":"Modeling of presymptomatic and symptomatic stages of parkinsonism in mice","volume":"181","year":"2011","journal-title":"Neuroscience"},{"key":"2025122610051089000_2025.12.20.695709v1.36","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700221"},{"key":"2025122610051089000_2025.12.20.695709v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105684"},{"key":"2025122610051089000_2025.12.20.695709v1.38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/ijms21020678","article-title":"Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer\u2019s Disease Brains","volume":"21","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"2025122610051089000_2025.12.20.695709v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106045"},{"key":"2025122610051089000_2025.12.20.695709v1.40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2015.06.004","article-title":"Characterization of the lipopolysaccharide induced model of Parkinson\u2019s disease: Role of oxidative stress and neuroinflammation","volume":"87","year":"2015","journal-title":"Neurochemistry International"},{"key":"2025122610051089000_2025.12.20.695709v1.41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1171-z"},{"key":"2025122610051089000_2025.12.20.695709v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.04.016"},{"key":"2025122610051089000_2025.12.20.695709v1.43","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-008-0352-8"},{"key":"2025122610051089000_2025.12.20.695709v1.44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.1999.00202.x"},{"key":"2025122610051089000_2025.12.20.695709v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.11.002"},{"key":"2025122610051089000_2025.12.20.695709v1.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04440.x"},{"key":"2025122610051089000_2025.12.20.695709v1.47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pbb.2012.02.011","article-title":"Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain","volume":"101","year":"2012","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"2025122610051089000_2025.12.20.695709v1.48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/1028415X.2017.1337290","article-title":"Agaricus blazei extract abrogates rotenone-induced dopamine depletion and motor deficits by its anti-oxidative and anti-inflammatory properties in Parkinsonic mice","volume":"21","year":"2018","journal-title":"Nutritional Neuroscience"},{"key":"2025122610051089000_2025.12.20.695709v1.49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnagi.2018.00237","article-title":"Additive effects of levodopa and a neurorestorative diet in a mouse model of Parkinson\u2019s disease","volume":"10","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"2025122610051089000_2025.12.20.695709v1.50","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.3390\/ijms21093254","article-title":"Chronic systemic exposure to low-dose rotenone induced central and peripheral neuropathology and motor deficits in mice: reproducible animal model of Parkinson\u2019s disease","volume":"21","year":"2020","journal-title":"International journal of molecular sciences"},{"key":"2025122610051089000_2025.12.20.695709v1.51","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.3390\/biomedicines10123174","article-title":"Systemic rotenone administration causes extra-nigral alterations in C57BL\/6 mice","volume":"10","year":"2022","journal-title":"Biomedicines"},{"key":"2025122610051089000_2025.12.20.695709v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.05.001"},{"key":"2025122610051089000_2025.12.20.695709v1.53","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/scd.2019.0208","article-title":"Adult neurogenesis in the context of brain repair and functional relevance","volume":"29","year":"2020","journal-title":"Stem cells and development"},{"key":"2025122610051089000_2025.12.20.695709v1.54","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav6885"},{"key":"2025122610051089000_2025.12.20.695709v1.55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1073858403252680","article-title":"Injury-induced neurogenesis in the adult mammalian brain","volume":"9","year":"2003","journal-title":"The Neuroscientist"},{"key":"2025122610051089000_2025.12.20.695709v1.56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/1673-5374.131567","article-title":"The potential of endogenous neurogenesis for brain repair and regeneration following traumatic brain injury","volume":"9","year":"2014","journal-title":"Neural regeneration research"},{"key":"2025122610051089000_2025.12.20.695709v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.10.029"},{"key":"2025122610051089000_2025.12.20.695709v1.58","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuron.2016.07.024","article-title":"Regrowth of serotonin axons in the adult mouse brain following injury","volume":"91","year":"2016","journal-title":"Neuron"},{"key":"2025122610051089000_2025.12.20.695709v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113089"},{"key":"2025122610051089000_2025.12.20.695709v1.60","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.872501"},{"key":"2025122610051089000_2025.12.20.695709v1.61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam9080"},{"key":"2025122610051089000_2025.12.20.695709v1.62","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-018-2650-4"},{"key":"2025122610051089000_2025.12.20.695709v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.021"},{"key":"2025122610051089000_2025.12.20.695709v1.64","doi-asserted-by":"crossref","unstructured":"de Soysa, T.Y. , Therrien, M. , Walker, A.C. , and Stevens, B. (2022). Redefining microglia states: Lessons and limits of human and mouse models to study microglia states in neurodegenerative diseases. (Elsevier), pp. 101651.","DOI":"10.1016\/j.smim.2022.101651"},{"key":"2025122610051089000_2025.12.20.695709v1.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24232-3"},{"key":"2025122610051089000_2025.12.20.695709v1.66","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3804-15.2016"},{"key":"2025122610051089000_2025.12.20.695709v1.67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520937113"},{"key":"2025122610051089000_2025.12.20.695709v1.68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80652"},{"key":"2025122610051089000_2025.12.20.695709v1.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.041"},{"key":"2025122610051089000_2025.12.20.695709v1.70","doi-asserted-by":"publisher","DOI":"10.3791\/54466"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2025.12.20.695709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:05:18Z","timestamp":1766772318000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2025.12.20.695709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":70,"URL":"https:\/\/doi.org\/10.64898\/2025.12.20.695709","relation":{},"subject":[],"published":{"date-parts":[[2025,12,23]]},"subtype":"preprint"}}